Busy. Please wait.

show password
Forgot Password?

Don't have an account?  Sign up 

Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.

Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.

Remove Ads
Don't know
remaining cards
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
restart all cards

Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

Dabigatran (oral)

ANTICOAGULANTS (Direct thrombin inhibitors)

Indication VTE Non-valvular AF + high risk of stroke /systemic embolism
Contraindication GI hemorrhage within previous 12 months Prosthetic heart valve MI
Adverse effects GI bleeding Gastritis ( inflammation (irritation) of the stomach lining) Dysepsia (discomfort or pain in the upper abdomen)
Mode of action For direct thrombin inhibitors: inhibit both free and fibrin-bound thrombin, preventing fibrinogen converting to fibrin, prevent thrombus formation
Route/dose Oral 10 days after THR VTE+ after surgery:110mg after 1-4hr of the surgery, then 220mg once daily AF, acute VTE: paren anticoagulant for 5 days before dabigatran, adults: elder= 150:110 x2 daily
How to remember Đã bị gạt rồi
Comments Antidote: idarucizumab
Created by: bttr